Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Biomed_101> ?p ?o. }
Showing items 1 to 15 of
15
with 100 items per page.
- Biomed_101 abstract "Biomed 101 is an experimental drug studied for its potential to reduce the side effects of administered Interleukin 2. IL-2 is a signaling molecule in the immune system, and has been tested in many clinical trials as an immunotherapy for the treatment of cancers, chronic viral infections and as adjuvants for vaccines. Biomed 101 has been shown not to affect interleukin-2 antitumor activity, and may alleviate IL-2's side effects such as IL-2-mediated hypoxia.".
- Biomed_101 wikiPageExternalLink drugdictionary.aspx?CdrID=37882.
- Biomed_101 wikiPageID "15523016".
- Biomed_101 wikiPageRevisionID "499235694".
- Biomed_101 hasPhotoCollection Biomed_101.
- Biomed_101 subject Category:Chemotherapeutic_adjuvants.
- Biomed_101 subject Category:Drugs.
- Biomed_101 subject Category:Experimental_cancer_drugs.
- Biomed_101 comment "Biomed 101 is an experimental drug studied for its potential to reduce the side effects of administered Interleukin 2. IL-2 is a signaling molecule in the immune system, and has been tested in many clinical trials as an immunotherapy for the treatment of cancers, chronic viral infections and as adjuvants for vaccines. Biomed 101 has been shown not to affect interleukin-2 antitumor activity, and may alleviate IL-2's side effects such as IL-2-mediated hypoxia.".
- Biomed_101 label "Biomed 101".
- Biomed_101 sameAs m.03md3yg.
- Biomed_101 sameAs Q4915097.
- Biomed_101 sameAs Q4915097.
- Biomed_101 wasDerivedFrom Biomed_101?oldid=499235694.
- Biomed_101 isPrimaryTopicOf Biomed_101.